OTCM
JKSM
Market cap9kUSD
Jul 10, Last price
0.00USD
1Q
-50.00%
IPO
-99.93%
Name
Jacksam Corp
Chart & Performance
P/E
—
P/S
0.01
EPS
—
Div Yield, %
—
Shrs. gr., 5y
12.80%
Rev. gr., 5y
-26.15%
Revenues
1m
-64.73%
Net income
-1m
L-17.23%
CFO
-311k
L-15.98%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
As a technology firm, Jacksam Corporation is dedicated to engineering and bringing to market sophisticated automation systems, primarily for vaporizer cartridge filling and capping, alongside pre-roll manufacturing. Their product line features advanced equipment such as the eShark and 710 Shark cartridge filling machines, the 710 Captain cartridge capping units, and PreRoll-ER systems designed for pre-rolls and cones, in addition to C-Cell cartridges. The company's customer base spans medical and recreational dispensaries, both large and small-scale processors and cultivators, multi-state operators, and distributors. Jacksam utilizes a multi-faceted sales strategy, encompassing a direct sales force, independent representatives, the sales teams of strategic partners, a referral network, and its official website. The organization serves the e-cigarette, vaporizer, and pre-roll sectors, with a particular focus on the medical and recreational cannabis, hemp, and CBD markets. Founded in 2013, the company's operations are based in Costa Mesa, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑09 | 2016‑09 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||